雲南鍺業(002428.SZ):2020年實現扭虧為盈 預盈1800萬元–2500萬元
格隆匯 1 月 28日丨雲南鍺業(002428.SZ)披露2020年度業績預吿,預計2020年度歸屬於上市公司股東的淨利潤1800萬元–2500萬元,上年同期虧損5914.53萬元;扣除非經常性損益後的淨利潤為虧損200萬元–盈利300萬元,上年同期虧損6098.63萬元。業績變動原因如下:
2020年鍺價較上年末小幅回升;紅外級鍺產品、光伏級鍺產品、半導體材料級產品銷量增加;
預計政府補助將增加公司2020年度淨利潤1900萬元至2400萬元,政府補助屬於非經常性損益,不具有可持續性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.